Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Annovis Bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ANVS
New York
8731
https://www.annovisbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Annovis Bio Inc
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
- Apr 29th, 2024 2:10 pm
Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade
- Apr 24th, 2024 1:55 pm
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
- Apr 23rd, 2024 12:09 pm
Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
- Apr 19th, 2024 3:57 pm
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
- Apr 19th, 2024 2:14 pm
DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
- Apr 18th, 2024 2:06 pm
Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
- Apr 17th, 2024 1:21 pm
Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
- Apr 16th, 2024 3:33 pm
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
- Apr 16th, 2024 1:14 pm
RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
- Apr 12th, 2024 2:23 pm
Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag
- Apr 12th, 2024 2:00 pm
Eyenovia (EYEN) Down 18% on Disappointing Corporate Update
- Apr 9th, 2024 1:29 pm
Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study
- Apr 8th, 2024 4:13 pm
Wall Street Analysts See a 218.92% Upside in Annovis Bio (ANVS): Can the Stock Really Move This High?
- Apr 8th, 2024 1:55 pm
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
- Apr 2nd, 2024 11:30 am
Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans
- Apr 1st, 2024 12:00 pm
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet
- Mar 21st, 2024 1:55 pm
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
- Mar 20th, 2024 11:30 am
Are Options Traders Betting on a Big Move in Annovis Bio (ANVS) Stock?
- Mar 18th, 2024 12:52 pm
Sell Signal: 3 Stocks to Unload Before the Bubble Bursts
- Mar 6th, 2024 8:33 pm
Scroll